We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

63 hedge funds and large institutions have $19.9M invested in Nymox Pharmaceutical Corp in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

813% more call options, than puts

Call options by funds: $621K | Put options by funds: $68K

214% more capital invested

Capital invested by funds: $6.32M → $19.9M (+$13.6M)

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

34% more funds holding

Funds holding: 47 → 63 (+16)

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

Holders
63
Holders Change
+16
Holders Change %
+34.04%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
12
Reduced
11
Closed
8
Calls
$621K
Puts
$68K
Net Calls
+$553K
Net Calls Change
+$567K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.53M
2
State Street
State Street
Massachusetts
+$1.33M
3
Northern Trust
Northern Trust
Illinois
+$1.29M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$769K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$507K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$999K
2
Millennium Management
Millennium Management
New York
-$909K
3
Goldman Sachs
Goldman Sachs
New York
-$433K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$156K
5
Renaissance Technologies
Renaissance Technologies
New York
-$143K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$121K +$1.57K +495 +1%
WS
27
Wedbush Securities
California
$112K -$7.28K -2,300 -7%
PAG
28
Private Advisor Group
New Jersey
$110K – – –
VF
29
Virtu Financial
New York
$100K +$89K +28,140 New
BAS
30
Brown Advisory Securities
Maryland
$92K – – –
GG
31
Gofen & Glossberg
Illinois
$89K – – –
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$89K +$79.7K +25,204 New
Goldman Sachs
33
Goldman Sachs
New York
$86K -$433K -136,752 -85%
WCWM
34
Willow Creek Wealth Management
California
$86K – – –
AIG
35
American International Group
New York
$86K +$76.3K +24,108 New
Barclays
36
Barclays
United Kingdom
$77K +$68.2K +21,569 New
Deutsche Bank
37
Deutsche Bank
Germany
$76K -$27.5K -8,683 -29%
SG Americas Securities
38
SG Americas Securities
New York
$76K +$67.3K +21,288 New
Wells Fargo
39
Wells Fargo
California
$76K +$68.2K +21,568 New
Brown Advisory
40
Brown Advisory
Maryland
$66K – – –
Credit Agricole
41
Credit Agricole
France
$64K – – –
WP
42
WMS Partners
Maryland
$64K – – –
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$63K -$999K -315,736 -95%
Creative Planning
44
Creative Planning
Kansas
$63K – – –
Citadel Advisors
45
Citadel Advisors
Florida
$63K +$56K +17,691 New
VOYA Investment Management
46
VOYA Investment Management
Georgia
$52K +$46.3K +14,648 New
UBS Group
47
UBS Group
Switzerland
$49K +$39.8K +12,597 +1,113%
Osaic Holdings
48
Osaic Holdings
Arizona
$42K +$21.8K +6,900 +138%
TRCT
49
Tower Research Capital (TRC)
New York
$41K +$36.5K +11,547 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$38K +$33.8K +10,700 New
1
2
3

NYMX Hedge Fund Activity: Q2 2020 in Review

63 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q2 2020, worth a combined $19.9M — up 214% from $6.32M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new NYMX positions and 8 closed out — a net gain of 16 holders — while 12 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $5.53M. The largest seller was Susquehanna International Group, cutting an estimated $999K.

  • 63 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q2 2020, up from 47 in Q1 2020.
  • Funds reported $19.9M of Nymox Pharmaceutical Corp stock for Q2 2020, up 214% quarter-over-quarter.
  • 24 funds opened new Nymox Pharmaceutical Corp positions in Q2 2020 and 8 closed out, a net change of +16 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q2 2020 was BlackRock, an estimated $5.53M added.
  • The largest Nymox Pharmaceutical Corp seller in Q2 2020 was Susquehanna International Group, an estimated $999K sold.

Based on aggregated 13F filings for Q2 2020.